New research confirms that Symprove re-balances the gut and improves health
Many probiotic products fail to reach where needed in the gut, food and dairy based products can trigger digestion resulting in the bacteria been destroyed by digestive enzymes and freeze dried probiotics often pass straight through unable to colonise the gut.
New research published in the International Journal of Pharmaceutics has confirmed that the ‘good’ bacteria in the live probiotic Symprove successfully reaches and colonises the gut.
Using in vitro methods, researchers used donor bacteria from healthy humans and observed how bacteria in Symprove survived stomach acid to arrive where needed and over time colonised the gut.
Simon Gaisford, Professor of Pharmaceutics at University College London said, “We’ve been able to show that delivering viable and active bacteria to the gut impacts the healthy bacteria in our bodies in a way that we’ve not seen before. The diversity of the donor microbiotas clearly changed for the better and importantly the effect was sustained week on week. We saw that the addition of Symprove reduced inflammatory markers and raised butyrate levels. If we can make a healthy microbiome healthier, the potential to improve conditions of dysbiosis is incredibly exciting.”
Researchers found that not only were butyrate levels increased (butyrate is a short-chain fatty acid, critical to health and wellbeing) levels of inflammatory cytokines, associated with inflammatory conditions and viral infections decreased whilst beneficial anti inflammatory cytokines levels were increased.